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Invasiona b s t r a c t
The invasion of CD71+ reticulocytes by Plasmodium vivax is a crucial yet poorly characterised event. The
application of flow cytometry to ex vivo invasion assays promises to facilitate the quantitative analysis of
P. vivax reticulocyte invasion. However, current protocols suffer from a low level of sensitivity due to the
absence of a particular design for P. vivax cell tropism. Importantly, merozoite invasion into contaminat-
ing red blood cells from the schizont inoculum (auto-invasion) may confound the analysis. Here we pre-
sent a stable two-color flow cytometry assay for the accurate quantification of P. vivaxmerozoite invasion
into intracellularly labelled CD71+ reticulocytes. Various enzymatic treatments, antibodies and invasion
inhibitory molecules were used to successfully demonstrate the utility of this method. Fluorescent label-
ling of red blood cells did not affect the invasion and early intra-erythrocytic development of P. vivax.
Importantly, this portable field assay allows for the economic usage of limited biological material (para-
sites and reticulocytes) and the intracellular labeling of the target cells reduces the need for highly puri-
fied schizont inoculums. This assay will facilitate the study of P. vivaxmerozoite biology and the testing of
vaccine candidates against vivax malaria.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Plasmodium vivax is the most widespread, difficult to diagnose
and treat cause of malaria. There are 70–130 million cases annu-
ally, mainly in Asia and the Americas, with 2.5 billion people cur-
rently at risk (Mendis et al., 2001; Gething et al., 2012). The
continual emergence of drug-resistant vivax malaria (Rijken
et al., 2011; Price et al., 2014) emphasizes the need for an effective
vaccine against P. vivax. Currently much of the vivax malaria vac-
cine development efforts have focused on the intra-erythrocytic
stage of the parasite (Vicentin et al., 2014; de Cassan et al., 2015;
Moreno and Joyner, 2015).However, the preclinical screening of vaccine candidates
against P. vivax merozoite invasion of erythrocytes has been ham-
pered by the absence of a successful continuous in vitro culture
protocol. Much of the difficulty in developing a culture method
for P. vivax is due to this species’ highly restricted tropism for
CD71+ reticulocytes (an early and short-lived stage of red blood
cell (RBC) development) (Kitchen, 1938; Mons et al., 1988;
Malleret et al., 2015). Therefore research into P. vivax invasion
has relied largely on ex vivo (Russell et al., 2012) or in vivo studies
of malaria-infected patients or non-human primates (Miller et al.,
1976, 1978; Nichols et al., 1987; Barnwell et al., 1989). In both
cases, fresh isolates are difficult to obtain, have low parasitemias
(below 0.5%) and mixed stages which further complicate the pre-
cise investigation needed to study RBC invasion. Consequently,
the preclinical development and testing of blood stage vaccines
against P. vivax have focused on biochemical assays (Adams
et al., 1992; Chitnis and Miller, 1994; VanBuskirk et al., 2004;
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(Batchelor et al., 2011) which do not provide final proof of the vac-
cine candidate effectiveness in blocking RBC invasion.
In 2011, Russell and colleagues established and validated a
microscopy-based assay using concentrated reticulocytes (target
cells) from cord blood and enriched mature parasites ex vivo from
patient isolates (Russell et al., 2011). While this methodology
allowed the initial investigation of different interventions, there
were important limitations: (i) the concentrated parasite inoculum
from a donor’s blood contains contaminating RBCs, including retic-
ulocytes (i.e. it is not possible to produce a 100% pure schizont
preparation) and (ii) during parasite enrichment, schizonts can
burst and release merozoites which are then free to invade the
contaminating endogenous reticulocytes before the target cells
are added. Microscopic observation will not differentiate between
parasites that have invaded contaminating reticulocytes (autolo-
gous invasion) and those that have invaded target reticulocytes,
thus confounding the precise measure of inhibitor efficacy against
the merozoite invasion. Furthermore, microscopy is laborious,
requires special training and lacks objectivity due to inter-reader
variability.
Recently, a study promoted the idea of flow cytometry for
observing P. vivax development with better accuracy, faster quan-
tification and larger total cell counts (Malleret et al., 2011). This
protocol was adapted for a drug susceptibility assays using a por-
table flow cytometer suitable for field laboratories (Russell et al.,
2013). The application of flow cytometry and magnetic concentra-
tion of schizonts (Ribaut et al., 2008) in a clinical setting in Thai-
land helped to specify the tropism of P. vivax merozoites for
CD71+ reticulocytes (Malleret et al., 2013, 2015). Although the flow
cytometry method improved the objectivity of P. vivax invasion
assays, it still suffers from the confounding background of autolo-
gous invasion.
In order to examine the invasion biology of P. vivax merozoites
and the efficacy of vaccine candidates/therapies, we require an
assay that can unambiguously detect the invasion of target cells
with a high degree of sensitivity and specificity. Here we introduce
a novel flow cytometry-based invasion inhibition assay adapted
from the assay developed by Theron et al. (2010). This assay can
distinguish newly invaded parasites from other endogenous con-
founding factors and reduces the need for highly purified parasite
inoculums by using an intracellular dye (carboxyfluorescein suc-
cinimidyl ester (CFSE)). In this study we adapted the method to
study P. vivax in field laboratories and enabled fast, efficient and
unambiguous investigation of P. vivax merozoite invasion.2. Materials and methods
2.1. Ethics statement
The clinical infected RBC (iRBC) and umbilical cord blood sam-
ples used in this study were collected under the following ethical
guidelines and approved protocols; OXTREC 027-025 (University
of Oxford, Centre for Clinical Vaccinology and Tropical Medicine,
UK) and MUTM 2008-215 from the Ethics committee of Faculty
of Tropical Medicine, Mahidol University, Thailand. The use of
human samples was approved by the National University of
Singapore Institutional Review Board (NUS-IRB reference no. 09-
256), and written informed consent was obtained from all
participants.2.2. Plasmodium vivax mature schizont enrichment
Clinical isolates of P. vivax were collected from malaria patients
receiving treatment from clinics operated by the Shoklo MalariaResearch Unit on the north-western border of Thailand. All patients
were briefed on the project and provided informed consent prior to
collection of blood by venipuncture. Five mL of whole blood were
collected in lithium heparin tubes. These samples were processed
for leukocyte-depletion using powdered cellulose (Sigma–Aldrich,
Singapore) columns, then were either cultured directly or cryopre-
served directly in Glycerolyte 57 (Baxter, USA) (Sriprawat et al.,
2009). Parasites were thawed as previously described (Blomqvist,
2008) and were cultured to the schizont stage in 10 mL of McCoy
5A medium supplemented with 2.4 g/L of D-glucose, and 20%
heat-inactivated human serum (matching blood type of donor),
in a gas mixture of 5% CO2, 5% O2 and 90% N2 at 37.5 C.
The P. vivax peripheral blood samples received at the clinic were
at different intra-erythrocytic stages with low parasitemias
(Fig. 1D). Consequently, a maturation step was required to max-
imise the yield of mature schizonts (Fig. 1E, F). At 40 h post-
cultivation, selection of the late developmental stages of P. vivax
containing hemozoin pigment was performed using the
magnetic-activated cell sorting (MACS) system (Miltenyi, Singa-
pore). Approximately 1 mL of blood at 50% hematocrit in McCoy
5A medium was passed through a ‘‘large depletion” (LD) column
as described previously (Ribaut et al., 2008). After washing twice
with 2 mL of McCoy 5A medium, the developmental stages were
collected from the magnetically-retained fraction. The mature
intra-erythrocytic parasites were then diluted in McCoy 5A
medium 1:2 and 0.2 ll added to make 0.1 ll of packed iRBCs per
well.
2.3. Enrichment and intracellular staining of reticulocytes
Twenty mL of uninfected cord blood were collected in lithium
heparin tubes from umbilical cords immediately after the delivery
of the child for all samples. The blood group was determined using
a TransClone ABO antisera kit (Bio-Rad, USA). After plasma
removal, the packed RBCs were washed in McCoy 5A medium. Host
white blood cells and platelets were depleted from the RBCs using
two rounds of powdered cellulose (Sigma–Aldrich) column filtra-
tion (Sriprawat et al., 2009).
CD71+ reticulocyte enrichment was done using the MACS sys-
tem (Miltenyi). Approximately 2 mL of blood at 50% haematocrit
(Hct) in PBS were mixed with CD71 MicroBeads (Miltenyi) and
passed through a large selection (LS) column to obtain a CD71
depleted (negative) fraction and a CD71-rich fraction (positive). A
LS column favors purity over quantity when sorting for the cell
of interest (positive fraction); in other words, some CD71+ reticu-
locytes can be lost in selection (negative fraction). The purity levels
of these fractions were verified by flow cytometry using nucleic
acid stain (Thiazole Orange, Sigma–Aldrich) and were corroborated
with the new methylene blue stain (Sigma–Aldrich) (Fig. 1A–C).
The use of erythrocyte labelling with CFSE in Plasmodium stud-
ies has been reported (Koka et al., 2008; Theron et al., 2010; Gallo
et al., 2012). Here we stained CD71+ reticulocytes with CFSE at
30 lM final concentration with 1% Hct in PBS for 30 min at room
temperature, followed by 5 min incubation with 1 mL of warm
FBS to stop the labelling reaction.
2.4. Invasion inhibition assay
The assay was set up in a 96-well flat-bottomed plate and each
well contained either no inhibitor (positive control) or different
inhibitors. In each well, 100 lL of complete McCoy 5A medium
and 0.8 lL of CFSE labelled RBCs (4 million erythrocytes) were
added to bring the final target cell Hct to 0.8%. To this, 0.1 lL of
magnetic positive fraction was added and, where required, candi-
date antibodies or mimetics were added before the complete set
up of the assay. Maturation was obtained after incubation in an
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Fig. 1. Preparation procedure for target cells and Plasmodium vivax parasites. (A, B) New methylene blue stained reticulocytes from cord blood before and after immune-
magnetic selection. (C) Flow cytometry of CD71 positive and negative fractions labelled with Thiazole orange after immune-magnetic sorting (Thiazole orange signal for X-
axis and side scatter signal, SSC for Y-axis). (D, E) Giemsa stain of P. vivax from infected patients maturing from early intra-erythrocytic phase to late stage schizonts. (F) After
magnetic sorting enrichment, two late stage parasites can be seen: schizonts (black arrows) and gametocytes (red arrows). Scale bars = 10 lm.
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assessed by flow cytometry and microscopy. The murine anti-Fy6
(2C3) murine antibody (1 mg/mL) (Wasniowska et al., 2002), the
anti-Fy6 single domain antibody (SdAb) (1 mg/mL) from a camelid
VHH library (Smolarek et al., 2010) and the small molecule inhibi-
tor against Merozoite Surface Protein (MSP)-1 (NIC: 2-butyl-5-chl
oro-3-(4-nitro-benzyl)-3H-imidazole-4-carbaldehyde, 50 mM)
were obtained as previously described (Wasniowska et al., 2002;
Smolarek et al., 2010; Chandramohanadas et al., 2014). The rabbit
azide-free monoclonal antibody (mAb) anti-FyB antibody
(0.31 mg/mL) was commercially purchased (Abcam, Singapore).
Antibodies were tested for inhibitory potential by using anti-Fy6
(2C3 epitope on DARC, Duffy antigen/chemokine receptor) anti-
body as a positive control. Both murine and camelid anti-Fy6 anti-
bodies were used at 20 lg/mL, NIC at 25 lM and anti-FyB antibody
at 18.6 lg/mL, respectively, in the final assay volume of 100 lL.
Invasion inhibition efficiency was calculated based on the
positive control (CD71+ reticulocytes only) after 24 h: (Inhibitionefficiency = 100  ((CFSE + Rings % with tested condition)/(CFSE
+ Rings % with positive control)  100)).
2.5. Microscopy
After 24 h, thin film smears were made for all samples and
stained with Giemsa (Sigma–Aldrich) for examination by light
microscopy. All fluorescent microscopy was done live with
samples in humidifying chambers, using Hoechst 33342
(Sigma–Aldrich) to stain the nuclear material. Cells were imaged
using a 100 oil immersion objective (Olympus IX73).
2.6. Determination of parasitemia by flow cytometry
At 0 h and 24 h of the assay, 20 lL of culture from each well
were mixed with 80 lL of PBS, then stained with 1 lL of Hoechst
33342 (Sigma–Aldrich) in a small curved bottom tube (Micronic,
Netherlands). After 20 min incubation at room temperature and
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staining reaction for immediate flow cytometry analysis (optimal
signal during the first 2 h post-staining). The absence of fixation
and/or permeabilisation steps reduces the risk of RBC agglutination
that can affect flow cytometry acquisition and analysis. At each
time point, the samples were acquired on an Accuri C6 (Becton
Dickinson, Singapore) using the near UV laser (427 nm) to detect
Hoechst 33342 and the blue laser for FITC (530 nm). The gating
strategy was based on methods by Malleret et al. (2011) and anal-
ysed using FlowJo (Tree Star, USA). When determining invasion
efficiency, we applied the same gating strategy to a CFSE+ target
cell-only control (no schizonts added) which was observed for
any non-specific background events. These events were used to
set a baseline for measuring ‘true’ parasite invasion efficiency into
CFSE+ target cells (Fig. 4D).
2.7. Enzyme treatment
Erythrocytes were pre-treated with either trypsin (1 mg/mL),
chymotrypsin (1 mg/mL) or neuraminidase (100 mU/mL) for 1 h
at 37 C. The enzyme treatment was stopped by washing three
times with warm PBS.
2.8. DNA extraction
Before any procedures commenced, dried blood spots of cord
blood and parasite-infected patient samples were made on What-
man filter paper and stored under sterile conditions. Alternatively,
200 lL of cultured parasites or human donor blood samples were
stored at 20 C until DNA extraction using a QIAamp DNA mini
kit (Qiagen, Santa Clarita, CA, USA).
2.9. PCR analysis and sequencing studies
Two PCRs were done for this project and the first PCR was done
to determine if blood donors were Duffy negative. Prior to the PCR,
phenotyping of Duffy negative donors was carried out on a flow
cytometer as previously described (Malleret et al., 2013).
Primers Fynull F & Fynull R (Supplementary Fig. S2A) were
designed to detect the C/T single nucleotide polymorphism (SNP)
inside the GATA box motif (Tournamille et al., 1995). The second
PCR was done to amplify a 586 bp product which includes the
MSP1-19 region, which was then sequenced to detect SNPs in the
predicted NIC binding site.
Each PCR contained 2.5–7 ng of DNA, 50 pmol of each primer,
2 nmol dNTPs, 1.0 U Phusion HF polymerase and buffer (Thermo
Scientific, Singapore) in a total volume of 25 lL. Primer sequences
are listed in Supplementary Fig. S2A.
The same PCR cycle conditions were used for both PCRs and the
amplification profile used was 98 C for 5 min followed by 30
cycles of denaturation at 98 C for 15 s; annealing at 63 C for
15 s; elongation at 72 C for 30 s; followed by a final 10 min
incubation at 72 C. Amplified products were subjected to elec-
trophoresis in 1% agarose gel in 0.5% Tris-Borate-EDTA (TBE) to ver-
ify the product quality, before PCR purification using a Qiagen kit
and then sent for sequencing in the forward direction on an auto-
mated sequencer (AITBiotech, Singapore).
2.10. Statistical analysis
Parametric comparisons of invasion/ inhibition efficiencies
were paired to be tested by either a Paired t test or an one-way
ANOVA with Tukey post hoc test. All statistical analyses used Prism
5 for Windows (Version 5.01), Mackiev software. P < 0.05 was
considered significant.3. Results
3.1. Human reticulocyte enrichment
Concentration of immature RBCs from cord blood (Fig. 1A) is a
non-invasive and efficient process. In the past, repeated powdered
cellulose filtration was necessary to deplete leukocytes (Russell
et al., 2011), however the introduction of non-woven fabric filter
now allows for faster processing of blood (Tao et al., 2011). After
leukocyte depletion and CD71 magnetic sorting, a mean of
88.58% CD71+ reticulocytes were obtained (95% confidence inter-
val (CI): 84.91–92.25%) (Fig. 1B). The CFSE-labelled erythrocyte
population was clearly distinguished from non-labelled erythro-
cytes under microscopy and flow cytometry (Fig. 2A, B).3.2. Plasmodium vivax maturation and enrichment
The mean volume of the P. vivax late stage parasites (LSPs) after
maturation and concentration from a 500 lL fresh isolate sample
was 1.03 lL (95% CI: 0.802 lL–1.27 lL). The mean purity of LSPs
was 36.3% (95% CI: 24.28–48.33%). Cryopreserved parasites also
had similar volumes (1.35 lL, 95% CI: 0.959 lL–1.74 lL) and LSP
concentrations (30.89%, 95% CI: 19.36–42.41%) compared with
fresh isolates. It is important to note that the magnetically concen-
trated LSPs comprised of schizonts and gametocytes (Fig. 1F). The
proportion of gametocytes in the LSP concentrate varied consider-
ably between P. vivax isolates (a range of 0–48% of LSPs were
gametocytes).3.3. Ex vivo invasion assay
After preparing target reticulocytes and LSPs, those were incu-
bated together for 24–26 h. Flow cytometry acquisition at 0 h
and 24 h was done using the laser configuration described in Sec-
tion 2.6, with additional microscopy observation at both of these
time points. Therefore, to a standard volume of 100 lL of McCoy
medium, 0.1 lL of packed iRBCs and 0.8 lL of CFSE-labelled target
reticulocytes were added (Fig. 2A). However, due to the variable
purity of schizonts after magnetic sorting (MACS), the ratio
between the target cells and parasite inoculum (1:8) was challeng-
ing to maintain. Nevertheless, there was no significant association
between the proportion of parasite population added at 0 h and
CFSE+ parasitemia at 24 h (Pearson’s correlation coefficient;
R2 = 0.1121, P = 0.4176).
At 0 h, a flow cytometry dot plot of CFSE/Hoechst shows three
defined populations and events were gated accordingly: LSPs, con-
taminating erythrocytes and the target CFSE+ reticulocytes
(Fig. 2B). After 24 h, two additional populations appeared; early
stage parasites that either invaded the contaminating erythrocytes
(CFSE negative) or target reticulocytes (CFSE positive) (Fig. 2B).
CFSE labelling did not affect RBC morphology nor parasite invasion.
Successful experiments were defined by positive controls of each
experiment which showed a clear cluster of CFSE+ iRBC popula-
tions higher than 0.75% at 24 h. For microscopic observations, only
rings and early trophozoites were counted. Dead rings and
unhealthy early stages were also counted as they could be indica-
tions of new invasion. Overall, the mean parasitemia from flow
cytometry acquisition at 24 h was 3.95% (95% CI: 1.23–6.63%)
and the mean parasitemia from microscopic examination was
3.63% (95% CI: 0.09–7.18%). Flow cytometry measurement was
comparable to that of microscopy (paired t test; P = 0.736), the gold
standard method for parasitemia observation, consistent with pre-
vious publications (Malleret et al., 2011; Russell et al., 2013).
We demonstrated that P. vivax invasion is dependent on the
proportion of CD71+ reticulocyte in the target cell population by
AB
Fig. 2. Schematic outline of the invasion assay using a diagram, micrographs and flow cytometry plots. (A) Diagram and corresponding micrographs showing different cell
populations present when parasite inoculum and target cells are added at 0 h and cultured for 24 h. Parasite DNA is visualised using Hoechst stain. Target cells stained with
carboxyfluorescein succinimidyl ester are in fluorescent green. Green arrows indicate CFSE+ target cells that have been invaded by Plasmodium vivax at 24 h whereas the blue
arrow shows P. vivax invasion into a contaminating endogenous CFSE red blood cell (RBC) population. Scale bar = 5 lm. (B) Flow cytometry gating strategy of the P. vivax
invasion assay, Hoechst/CFSE dot plot at 0 h and 24 h with forward scatter/side scatter (FSC/SSC) back-gating for each cell population at 0 h: RBCs CFSE (blue gate), RBCs
CFSE+ (green gate), parasite late stages (purple gate) and at 24 h: rings CFSE (blue gate), rings CFSE+ (green gate) and unburst schizonts (purple gate).
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negative fraction. The mean percentage of CD71+ reticulocytes in
the negative fraction was 5.50% (95% CI: 1.49–9.50%) and after
the LD column step the mean value decreased further to 1.87%
(95% CI: 6.39–10.13%). As expected, we saw a positive correlation
between invasion efficiency and the CD71+ reticulocyte percent-
age. The mean value of invasion efficiency was 36.95%. ± 8.66 forthe negative fraction from LS column which was significantly
higher than the control (anti-Fy6) (one-way ANOVA; P < 0.01)
and 17.05%. ± 5.11 from the negative fraction of the LD column
(Supplementary Fig. S1).
Mean parasitemia for targeted cells at 24 h was 3.60% (95% CI:
1.15–6.04%) and for contaminant RBCs was 0.56% (95% CI: 0.18–
0.94%) (Fig. 4A). Significant differences in parasitemias between
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Fig. 3. Agreement between microscopy and flow cytometry in determining inhibition efficiency. (A–D) Inhibition efficiency (%) of merozoites from enriched Plasmodium vivax
schizonts in the presence of different inhibitors. (A) Murine anti-Fy6 (2C3) antibody (n = 8 isolates). (B) Camelid anti-Fy6 antibody (n = 7 isolates). (C) Anti-FyB antibody (n = 8
isolates). (D) NIC (2-butyl-5-chloro-3-(4-nitro-benzyl)-3H-imidazole-4-carbaldehyde) (n = 8 isolates). (E) Bland-Altman comparisons of inhibition efficiencies for all tested P.
vivax inhibitor candidates (n = 31 isolates) were determined by microscopy and flow cytometry. The upper and lower 95% limits of agreement are denoted by the dotted lines.
36 J.-S. Cho et al. / International Journal for Parasitology 46 (2016) 31–39the two erythrocyte populations indicated that the contaminant
reticulocytes are not preferentially invaded when the target cell-
parasite inoculum ratio is followed (paired t test; P = 0.014).
3.4. Invasion inhibition assays
Murine anti-Fy6 (2C3) antibody exhibited a high reduction in
parasite invasion in a previous study (Russell et al., 2011), thus it
was used as a control inhibitor throughout this study (mean
87.65%; SD ± 9.17). Camelid anti-Fy6 (2C3) antibody showed simi-
lar inhibition efficiency (mean 91.56%; SD ± 3.65) (Fig. 4B) whereas
the inhibition efficiency of anti-FyB antibody (mean 53.06%;
SD ± 30.14) and NIC (mean 48.59%; SD ± 29.11) was significantly
lower (one-way ANOVA, P < 0.05 (anti-FyB), P < 0.01 (NIC))
(Fig. 4B).
Inhibition efficiency of conditions for microscopy and flow
cytometry were paired and displayed for each tested inhibitor(Fig. 3A–D). These matched results were combined and analyzed
to test the reliability of flow cytometry compared with the micro-
scopy method. Bland-Altman analysis indicated good agreement
between different intervention methodologies, with a slight bias
towards higher inhibition efficiency with the microscopy method
(0.0996 log10 units) (Fig. 3E).
3.5. Other applications
Trypsin, Chymotrypsin and Neuraminidase are three enzymes
commonly used to examine the invasion of erythrocytes by para-
sites (Barnwell et al., 1989). As expected, chymotrypsin treatment
abrogated invasion (mean 83.00%; SD ± 15.05) whereas trypsinised
cells showed partial disruption to parasite invasion (mean 59.11%;
SD ± 26.50) (Fig. 4C). Both treatments showed no significant differ-
ence in invasion inhibition efficiency compared with the control.
Neuraminidase treatment of RBCs often resulted in increased RBC
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D. ± 15.05) using murine anti-Fy6 antibody (20 lg/mL; mean 84.59%; S.D. ± 11.59) as a control (n = 5 isolates for all). (D) The mean invasion efficiency of Duffy negative
reticulocytes; Donor #1 (mean 10.97%; S.D. ± 9.80), Donor #2 (mean 10.66%; S.D. ± 6.57), Donor #3 (mean 9.52%; S.D. ± 5.90), (n = 3 isolates for Donor 1; n = 4 isolates for
Duffy positive control and Duffy negative Donors 2 and 3) Dotted line reflects CFSE+ Hoechst+ events acquired by a flow cytometer at 24 h in a CFSE+ target red blood cells
only control well. Asterisks indicate statistical significance determined with a one-way ANOVA with Tukey post hoc test (*P < 0.05; **P < 0.01; ***P < 0.001; n.s. not significant).
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the enzyme.
Plasmodium vivax did not invade reticulocytes from three Duffy
negative African donors (Fig. 4D). The invasion efficiency into each
reticulocyte sample was: Donor #1 (mean 10.97%; S.D. ± 9.80),
Donor #2 (mean 10.66%; S.D. ± 6.57), Donor #3 (mean 9.52%; S.
D. ± 5.90). They were all significantly lower than Duffy positive
reticulocytes (one-way ANOVA, P < 0.001).4. Discussion
Accurate analysis of P. vivax invasion assays is essential for the
assessment of neutralising antibodies and thus discovery and pre-
clinical development of new vaccine targets and chemical inhibi-
tors of invasion. The use of CFSE labeling of target cells in
combination with flow cytometry allows for the unambiguous
and quantitative determination of P. vivax invasion. CFSE labelling
not only differentiates between target and autologous invasions; it
also excludes other confounding events such as slow growing rings
or dead parasites from the 0 h parasite inoculum (Fig. 2B). More-
over, the CFSE processing of target reticulocytes does not appear
to affect the receptiveness of the labeled reticulocytes compared
with the health of parasite CFSE- contaminating RBCs (Fig. 4A).
These results are in line with past studies showing that CFSElabelling does not affect Plasmodium falciparummerozoite invasion
of normocytes (Theron et al., 2010).
To demonstrate the utility of this assay, we used a range of anti-
bodies and inhibitors known to abrogate P. vivax merozoite inva-
sion (Fig. 4B). All invasion inhibition efficiencies were calculated
using the parasitemia from the treated well versus the
intervention-free positive control. Importantly, the data from dif-
ferent experiments was not normalised using the respective LSP
population at 0 h for two reasons. First, the LSP population includes
gametocytes and late trophozoites in addition to schizonts that do
not egress within the incubation time. The presence of gameto-
cytes in peripheral parasitemia is more frequent in P. vivax infec-
tion than P. falciparum (McKenzie et al., 2006). Under flow
cytometry, it is difficult to differentiate gametocytes from sch-
izonts, and factors that drive differentiation into gametocytes are
still unknown. Second, there is no significant association between
the proportion of LSP that was added at 0 h and that of newly iRBCs
at 24 h. A positive control for each isolate will elucidate the
approximate proportion of merozoites which successfully invaded
RBCs. Thus, CFSE+ parasitemia from the positive control can be
used to normalise the results from the same isolates to compare
the effects of different interventions or conditions.
Although the emergence of Duffy antigen/chemokine receptor
(DARC)-independent P. vivax isolates have been reported
(Menard et al., 2010, 2013), merozoite invasion of P. vivax strains
from Thailand into erythrocytes is DARC-dependent (Russell
Table 1
Comparison of different methodologies to study parasite development and invasion. The Inhibition Assay includes antibody or therapeutic inhibitors. Tropism studies refer to
observation of various Plasmodium spp. cell tropism and effects of mutants or red blood cells with different phenotypes on Plasmodium vivax invasion.
Methodology Advantage Disadvantage Inhibition assay Tropism
studies
Microscopy Morphology observation Time consuming U (With limitation) X
Qualitative and quantitative evidence Special training required
Low cost Inter-reader variability
Donor and target cell populations are not distinguished
Flow Cytometry
(FC)
Objective Morphology cannot be observed U (With limitation) X
Fast Debris can be counted as events
More cells counted with less samples Dead or slow-growing parasites cannot be excluded
Reduced inter-operator variability Donor and target cell populations are not distinguished
FC with target cell
labelling
Objective Morphology cannot be observed U U
Fast Debris can be counted as events
More cells counted with less samples May be not be suitable for some invasion inhibitory
compounds with fluorescent properties
Reduced inter-operator variability
Donor and target cell populations
differentiated
Accurate quantification of parasite invasion
into target cell
Optimised for portable flow cytometer
(usable in field settings)
X, non-quantifiable.
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antibodies against the 2C3 epitope on DARC (anti-Fy6) and anti-
FyB monoclonal antibody against a Duffy antigen could be used
to validate the assay.
The inhibition efficiency of anti-FyB antibodies varied within
different reticulocyte samples. This variation may be associated
with the Fy phenotype of cord blood donors which needs to be
assessed. The FyB allele frequency in the south-eastern Asia region
is reported to be below 10% (Howes et al., 2011), thus we did not
expect anti-FyB antibody to inhibit P. vivax invasion. However,
although inhibition efficiency compared with anti-Fy6 antibody
was significantly less, mean inhibition efficiency of anti-FyB was
still over 50% (Fig. 4B). The possible reason for this is that FyB
(Asp) differs by one amino acid residue from FyA (Gly) and this
may cause partial binding of antibody which may affect parasite
invasion.
To demonstrate a wider utility of the assay we used NIC, a small
molecule shown to inhibit merozoite invasion through its interac-
tion with MSP-1 (Chandramohanadas et al., 2014). NIC-mediated
invasion inhibition was highly variable depending on the parasite
isolate (Fig. 4B). However, DNA sequencing results showed com-
plete conservation at the putative binding region of NIC on all P.
vivax MSP-1 genes of parasite isolates (Supplementary Fig. S2C)
(Chandramohanadas et al., 2014). This suggests that MSP-1
involvement in invasion may be redundant in some P. vivax iso-
lates, however this clearly deserves further investigation.
While this assay is particularly useful in observing antibodies or
inhibitors that have a specific target(s) in the merozoite invasion
process, it may not have a greater advantage for parasiticidal or
growth-inhibitory drugs compared with microscopy. In fact, some
inhibitory compounds may have fluorescent properties that could
interfere with the sensitivity of the new assay (Table 1). On the
other hand, target cell labelling allowed investigations using RBCs
with various phenotypes (from either genetic deficiencies or mod-
ifications). For example, we confirmed the in vivo study that shows
the DARC-dependence of P. vivax (Miller et al., 1978) under ex vivo
conditions by using Duffy negative RBCs (Supplementary Fig. S2A,
B) from three African donors instead of introducing different inhi-
bitors (Fig. 4D). Similarly, our assay can be utilised to study the
effects of enzymatic treatment on RBCs (Fig. 4C) and the host cell
tropism of different Plasmodium spp. by introducing various target
cells with different phenotypes (data not shown).The comparability between microscopy and flow cytometry in
detecting parasitemia and drug sensitivity was demonstrated pre-
viously (Malleret et al., 2011; Russell et al., 2013). Here, we present
the agreement between the twomethods in determining inhibition
efficiency, thus supporting flow cytometry as a sensitive means to
verify potential inhibitors. In addition to the ability to distinguish
debris, 50,000 events/cells were acquired by flow cytometry com-
pared with 1000 cells counted using a microscope which indicates
that the overall sensitivity and specificity (due to CFSE differentia-
tion) is increased by this novel assay whilst using less parasites and
reticulocytes (Table 1). Also, cytoplasmic labelling reduced the
requirement for high purity and yield for LSP concentration
(Fig. 2B) and negated the need for an extra trypsin treatment prior
to parasite concentration with Percoll (isotonic) which may affect
invasion (Carvalho et al., 2010; Russell et al., 2011).
Flow cytometry has lower inter-operator variability and can
obtain the results quickly, which is desirable for high throughput
screening. We hope that this field applicable flow cytometry inva-
sion assay, based on the successful Theron et al. (2010) P. falci-
parum invasion assay, will help facilitate the investigation of P.
vivax merozoite invasion biology and accelerate the screening of
new vaccine candidates against vivax malaria.
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